Responses
Other responses
Jump to comment:
- Published on: 19 April 2001
- Published on: 19 April 2001
- Published on: 19 April 2001Age as a risk factor for hemorrhage in aspirin usersShow More
April 3, 2001
To the Editor:
It seems that there is a potential flaw in the analysis by Sanmuganathan, et al (1), of the relative risk benefit ratio in the use of aspirin for the primary prevention of coronary artery disease. The coronary risks are calculated using tables in which age is a major determinant, but the risks of a bleeding complication are averaged over all ages. Since bleeding complicat...
Conflict of Interest:
None declared. - Published on: 19 April 2001Re: Age as a risk factor for hemorrhage in aspirin usersShow More
Dear Editor,
Dr Levitt has raised a valuable point that the risk benefit relationship of aspirin may vary with age as well as CHD risk and it is worth re-evaluating the conclusions made in our paper [1].
He has however misunderstood the way in which we calculated benefit from aspirin treatment. Because haemorrhagic strokes were not always reported separately they had to be included in cardiovascular e...
Conflict of Interest:
None declared.